Congress glumly moves towards Medicare drug benefit: but the cost is expected to be very high, and coverage limited.
Greenberg
Daniel
D
D000368:Aged; D003365:Costs and Cost Analysis; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics* / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States